048530 — iNtRON Biotechnology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Market Cap
KR₩137bn
Enterprise Value
KR₩98bn
Revenue
KR₩6bn

Annual balance sheet for iNtRON Biotechnology, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	83,497	47,351	57,184	49,843	41,839
Net Total Accounts Receivable
Net Total Receivables	40,641	65,268	2,697	1,203	1,077
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	125,513	113,928	60,980	52,226	43,815
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13,758	15,031	22,696	19,740	20,602
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	153,365	140,959	98,615	86,375	74,322
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	33,254	32,218	786	1,338	4,086
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	52,016	34,777	1,880	2,602	4,448
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	101,349	106,181	96,734	83,773	69,873
Total Liabilities & Shareholders' Equity	153,365	140,959	98,615	86,375	74,322
Total Common Shares Outstanding
Total Preferred Shares Outstanding